New clinical affairs VP for WorldHeart
This article was originally published in RAJ Devices
Executive Summary
Monica Hope has joined WorldHeart, a US-based developer of mechanical circulatory systems, as vice president of clinical affairs. Dr Hope will be responsible for conducting current and future clinical trials of WorldHeart's products. Dr Hope was previously director of clinical affairs at Second Sight Medical Products, a privately held US firm that is developing a retinal prosthesis for patients blinded by outer retinal degeneration. Salt Lake City, Utah-based WorldHeart is developing a ventricular device, Levacor, which it claims is the only fully magnetically levitated, bearingless, implantable centrifugal pump to move into clinical trials.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.